Jul 28, 2025 08:45AM

Jul 28, 2025 08:45AM

Jun 23, 2025 06:59AM

May 8, 2025 06:50AM

Apr 22, 2025 06:59AM

Apr 22, 2025 06:59AM

Jan 30, 2025 04:04PM Aclaris Therapeutics (ACRS) Forms New Scientific Advisory Board

Jan 30, 2025 04:01PM

Jan 10, 2024 07:00AM

Jan 10, 2024 07:00AM

Nov 13, 2023 10:39AM

Nov 8, 2022 07:00AM

Nov 18, 2021 04:01PM

Sep 23, 2021 08:33AM Aclaris Therapeutis (ACRS) Base Case Supported by FDA Approval of JAK Inhibitor Cream - Jefferies

Aug 30, 2021 07:54AM

Jun 9, 2021 09:27AM

Jun 8, 2021 05:54PM

Jan 20, 2021 09:20AM

Jan 19, 2021 05:44PM

Jul 8, 2020 09:24AM

Jul 7, 2020 05:49PM After-Hours Movers 07/07: (FTI) (ACRS) (GNMK) Higher; (LEVI) Lower (more...)

Jul 7, 2020 04:02PM

Jul 7, 2020 04:01PM

Jun 17, 2020 09:27AM

Jun 17, 2020 07:04AM

Jun 17, 2020 07:01AM

Nov 7, 2019 04:01PM

Oct 24, 2019 04:51PM Aclaris Therapeutics (ACRS) Reports A-101 45% Topical Solution Meets Primary/Secondary Efficacy Endpoints in 2nd Ph.3 Clinical Trial for Treament of THWART-1

Oct 24, 2019 04:01PM

Oct 22, 2019 09:30AM

Oct 8, 2019 05:03PM

Oct 8, 2019 05:01PM

Sep 18, 2019 07:51PM

Sep 16, 2019 04:17PM

Sep 16, 2019 04:15PM Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)

Sep 10, 2019 07:30PM

Sep 3, 2019 10:30PM

Aug 27, 2019 08:00AM

Aug 18, 2019 07:30PM

Aug 11, 2019 07:25PM

Aug 8, 2019 04:01PM

Aug 5, 2019 09:30PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, 3M Company, and Aclaris Therapeutics and Encourages Investors to C

Jul 30, 2019 08:20PM

Jul 30, 2019 04:39PM

Jul 30, 2019 04:01PM

Jul 9, 2019 07:03AM

Jul 9, 2019 07:00AM

Jul 7, 2019 09:30PM

Jul 5, 2019 05:44AM Aclaris Therapeutics (ACRS) Names Maxine Gowen to Board

Jul 3, 2019 04:01PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All